<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1">
<!-- Latest compiled and minified CSS -->
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/css/bootstrap.min.css">
<!-- Optional theme -->
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/css/bootstrap-theme.min.css">
<!-- Latest compiled and minified JavaScript -->
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.4/js/bootstrap.min.js"></script>
<style>img { width: 150px; height: auto; }</style>
</head>
<body role="document">
<div class="container theme-showcase" role="main">
<h3>safety vaccines experimental</h3>
<table>
<tr><td>T</td><td colspan=2>safety vaccines experimental</td></tr>
</table><hr><table>
<tr><td>2015-03-26 22:15:39</td><td>"Now we must move forward to adapt and expand the study so that ultimately we can determine whether these experimental vaccines can protect against Ebola virus disease and therefore be used in future Ebola outbreaks."</td></tr>
<tr><td>2015-03-26 22:15:41</td><td>Two experimental Ebola vaccines pass safety test in African trial</td></tr>
<tr><td>2015-03-27 04:26:17</td><td>Two experimental Ebola vaccines "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said.</td></tr>
<tr><td>2015-03-27 04:26:17</td><td>Based on the encouraging safety results, the study may now advance to the next phase of efficacy testing, in which additional volunteers are injected and assessed to see whether their immune system responds by producing anti-Ebola antibodies.</td></tr>
<table></body></html>